This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

1 Nov 2011

Cobra Biologics Buys Unitech Pharma

UK's Cobra Biologics acquires Unitech Pharma Group and its bioproduction facility in Sweden.

UK-based Cobra Biologics has acquired Unitech Pharma Group and its bioproduction facility in Matfors near Sundsvall, Sweden, expanding capacity and biopharmaceutical service offerings.


Unitech has a 600L clinical and commercial microbial GMP production capacity, commercial aseptic fill/finish and lyophilization capability.


Cobra’s service offering now includes cell line development, analytical and process development, GMP production, fill/finish, product release for Phase I, II, III clinical trials and in-market supply.


Peter Coleman, chief executive officer of Cobra, said, “The facility in Matfors will bring over 20 years of bio-production experience to Cobra, with their off

Related News